SEARCH

SEARCH BY CITATION

References

  • 1
    Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395403.
  • 2
    Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 647.
  • 3
    Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698703.
  • 4
    Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, Pappalardo E, Mannucci PM. Risk factors for thrombophilia in extra-hepatic portal vein obstruction. Hepatology 2005; 41: 6038.
  • 5
    Desmarais S, de Moerloose P, Reber G, Minazio A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347: 13745.
  • 6
    Manten B, Westendorp RGJ, Koster T, Reitsma PH, Rosendaal FR. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost 1996; 76: 5103.
  • 7
    Martinelli I, Cattaneo M, Panzeri D, Mannucci PM. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 1997; 77: 4403.
  • 8
    Baglin TP, Brown K, Williamson D, Baker P, Luddington R. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden in a United Kingdom population. Thromb Haemost 1997; 77: 1219.
  • 9
    Turkstra F, Karemaker R, Kuijer PM, Prins MH, Büller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost 1999; 81: 3458.
  • 10
    De Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000; 110: 1259.
  • 11
    Biörgell O, Nilsson PE, Nilsson JA, Svensson PJ. Location and extent of deep vein thrombosis in patients with and without FV:R 506Q mutation. Thromb Haemost 2000; 83: 64851.
  • 12
    Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, Di Minno G. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000; 118: 140511.
  • 13
    Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M, Aiach M, Fischer AM, Sors H, Fiessinger JN. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med 2001; 110: 125.
  • 14
    Friedline JA, Ahmad E, Garcia D, Blue D, Ceniza N, Mattson JC, Crisan D. Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes. Arch Pathol Lab Med 2001; 125: 10511.
  • 15
    Moser KM, Lemoine JR. Is embolic risk conditioned by location of deep vein thrombosis? Ann Int Med 1981; 94: 43944.
  • 16
    Lagerstedt CI, Olsson C-G, Fagher BO, Öqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985; 72: 5158.
  • 17
    Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ. Lower extremity calf thrombosis: to treat or not to treat? J Vasc Surg 1991; 14: 61823.
  • 18
    Leroyer C, Mercier B, Escoffre M, Ferec C, Mottier D. Factor V Leiden prevalence in venous thromboembolism patients. Chest 1997; 111: 16036.
  • 19
    Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni E. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92: 23538.
  • 20
    Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin Thromb Hemost 2005; 31: 1424.
  • 21
    Perrier A. Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors? Chest 2000; 118: 12346.
  • 22
    Vandenbrouke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JHJM, Manten B, Reitsma PH. Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 1998; 79: 5116.
  • 23
    Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 2000; 356: 1823.
  • 24
    Kraaijenhagen RA, Lensing AW, Wallis JW, van Beek EJ, ten Cate JW, Büller HR. Diagnostic management of venous thromboembolism. Baillieres Clin Haematol 1998; 11: 54186.